Uspešnost ablacije tkivnih ostataka kod terapije diferentovanog tireoidnog karcinoma radioaktivnim jodom
Medicinski glasnik
E-mail
cigotanuklearna@gmail.com
Ustanova
Odeljenje nuklearne medicine Specijalne bolnice Čigota, Zlatibor
Reference
Remnant ablation (RA) success and differentiated thyroid carcinoma (DTC) outcome in Stage III/IV patients: Recombinant human thyrotropin (rhTSH) vs. thyroid hormone withdrawal (THW); J. Vallejo, L. Mena, M. Gálvez and J. Latre; J Nucl Med May 2011 vol. 52
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer; Ujjal Mallick, F.R.C.R. et al; N Engl J Med 2012; 366: 1674–85.
Sažetak
Uspešnost ablacije tkivnih ostataka kod terapije diferentovanog tireoidnog karcinoma radioaktivnim jodom.
| Preuzmi | Veličina |
|---|---|
| 06_-_57.pdf (153.55 KB) | 153.55 KB |